TD-1473 for Active Ulcerative Colitis (UC)

Trial Details

  • 40 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Study drug TD-1473 or placebo
  • Clinic: Gulf Coast Research Group 4100 S. Shepherd Dr. Houston, TX 77098, Houston, Texas, United States

Summary

This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TD-1473 in subjects with moderately-to-severely active UC over 28 days. This exploratory study will also serve as a signal seeking endeavor to demonstrate biologic effect associated with TD-1473 through biomarker analysis and clinical, endoscopic, and histologic assessments.

Researchers

Screen shot 2017 07 12 at 3.52.55 pm
Gastroenterologist

Full Trial Details